NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
Clinical Trials
12 trialsNCT02921022 2025-11-26
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT05625932 2025-08-22
PROTINCOL
Galician Research Group on Digestive Tumors
Phase 3 Completed
NCT05957822 2024-05-14
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
Phase 4 Recruiting
NCT06065592 2023-10-06
CAT_PB
Lebanese University
Phase 1 Unknown
NCT05178628 2022-03-29
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Phase 3 Unknown
NCT05067153 2021-10-05
TOP-RCT
University of Aarhus
Phase 4 Unknown
NCT02444572 2021-07-29
ENOXACARE
Les Laboratoires des Médicaments Stériles
Phase 4 Completed
NCT00031837 2015-10-14
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
Phase 3 Terminated
NCT01945879 2013-09-19
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Phase 1/2 Completed
NCT00462852 2013-08-12
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00662688 2013-03-13
PAM07
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Terminated